Physiomics gains new speciality pharma customer for drug discovery research

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a contract with a new speciality pharma customer, to investigate how one of its new candidate drugs shrinks tumours.

Read more.

})(jQuery)